Low Dose Lignocaine Injections as a Treatment Option for Acute Lumbosacral Radiculopathy
Pain, Acute
About this trial
This is an interventional treatment trial for Pain, Acute
Eligibility Criteria
Inclusion Criteria:
- Age between 18 years to 60 years
- Pain involving up to two segmental levels (L4, L5 and S1).
- Average pain score of ≥5 on an 11-point NRS.
- Tenderness over the concordant peripheral nerves (Gore sign +)
- Computed tomography/Magnetic resonance imaging evidence of nerve root pain concordant with the side and level of clinical features.
Exclusion Criteria:
- Coagulopathy and/or patients on anticoagulants.
- Infection at the site of injection.
- Hypersensitivity to a local anaesthetic agent.
- Evidence of significant sensory or progressive motor deficit.
- Presence of cancer as a cause of back pain.
- History of previous backs surgery/epidural steroid injection.
Sites / Locations
- AIIMSRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Intervention group
Control group
Patient received one or two peripheral nerve blocks at a maximum according to their involvement in the operation theatre, with full ASA monitoring under all aseptic precautions. For L4 radiculopathy Saphenous nerve block with 1.5ml of 2% lignocaine diluted to 10ml (0.3%) For L5 radiculopathy Deep peroneal nerve block/posterior tibial nerve block with 1.5ml of 2% lignocaine diluted to 10ml (0.3%) For S1 radiculopathy Sural nerve block with 1.5ml of 2% lignocaine diluted to 10ml (0.3%)
Patients received one or two peripheral nerve blocks at a maximum according to their involvement in the operation theatre, with full ASA monitoring under all aseptic precautions. For L4 radiculopathy Saphenous nerve block with 10ml distilled water For L5 radiculopathy Deep peroneal nerve block/posterior tibial nerve block with 10ml distilled water For S1 radiculopathy Sural nerve block with10ml distilled water